You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A blogger reports on how personalized medicine has made headway in clinical trials for multiple myeloma.
A genetic nondiscrimination bill that's been floating around the US Congress for the past 12 years now looks like it may be passed.
GTO scans today's issue of Nature.
The developer of the Fortran programming language dies at 82.
Scientists are already feeling the effects of the NIH budget crunch.
Is trying to thwart malaria worth the unknown factors in releasing genetically modified mosquitoes into the environment? The jury's still out.
A blogger tackles the criticism leveled at the Cancer Genome Atlas project.
In six years, 8,000 human genes became no more.
The latest PNAS issue features a paper on recombination hotspots.
Google's Summer of Code event will include opportunities to help out the Phyloinformatics Group.
NIH Director Elias Zerhouni says the US must change its policy on stem cell funding.
An article online at Newsweek says the Cancer Genome Atlas could be a colossal waste of funding.
Just in case you were in a happy mood, here's a post on why genomic technologists should remember the cautionary tale of the eugenics movement.
As genetic testing is possible for more diseases, there's growing debate over the value of such tests when there's nothing to be done about the illness.
There's controversy brewing over how to regulate generic versions of biotech drugs.
An article in Forbes presents the argument that if we don't understand our own cellular network, we can't possibly expect to make it work better.
Here are the articles worth your time in this week’s Science.
The latest version of Sony's PlayStation lets users contribute to a global proteomics project.
A blogger discusses sequencing choices.
We take a look at this week's edition of Nature.
Emma Darwin’s diaries go digital.
A recent science fair shows that 'omics technologies are even hitting high schools.
A look at the politicized field of human embryonic stem cell research.
The Wall Street Journal has an article on the comeback of IPOs.
A blogger mourns after getting a negative review from a journal.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.